Friday August 11th, 2023, 2:00 PM to 4:00 PM
Grateful Heart Holistic Therapy Center presents
Ketamine Assisted Psychotherapy: A Transformative Treatment Option
with Celeste Monnette, LCSW (CA LCS22402), and Suegee Tamar-Mattis, DO (CA 20A10413), from Evolve Mind Wellness
2 CEs available
Visit our Continuing Education Credit page for more information about general CE training policies and procedures.
Ketamine Assisted Psychotherapy (KAP) is at the forefront of the psychedelic psychotherapy movement. When used under proper medical and therapeutic supervision, ketamine can provide relief from emotional pain, while helping individuals look deeply into themselves. It has been shown to quickly help with Treatment Resistant Depression (TRD) as well as chronic suicidal ideation. KAP can be a powerful tool to examine the unconscious processes that keep one stuck in damaging or obsessive patterns.
We find that ketamine’s healing potential is most effective when combined with psychotherapy from a trained provider. KAP has been used to successfully treat PTSD, anxiety disorders, developmental trauma, phase of life issues, as well as helping clients navigate the end of life and explore spirituality. With careful attention to science, safety, and the individual needs of each client, KAP can lead to healing and transformation. This work can help clients transcend long-held narratives, feeling/mood states, and struggles that they may be having difficulty shifting with traditional psychotherapy and/or psychopharmacology alone.
While there continues to be progress with clinical trials using psilocybin and MDMA to treat mental health disorders, ketamine is the psychedelic medicine that can currently be legally prescribed and supervised by trained, licensed professionals. Join our workshop presented by the team from Evolve Mind Wellness to learn more about this modality and how you can collaborate with psychedelic therapists to assist your clients in deepening their work.
About the Presenters
Celeste Monnette, LCSW, is a licensed psychotherapist with over 25 years of experience. She earned her Master’s degree in Social Welfare from UC Berkeley and has worked in community-based nonprofits and private practice. In 2005, she completed a two-year, post-graduate training program at The Psychotherapy Institute in Berkeley. Since, she has been working with clients with a broad range of goals for symptom relief and healing through various therapeutic modalities. After discovering the power of Ketamine to heal and reduce suffering, Celeste’s professional focus and development began to center around ketamine work and psychedelic integration. Celeste is currently enrolled in the MDMA Therapy Training Program and has a particular interest in trauma and trauma-informed care. She recently co-authored a publication on Ketamine Assisted Psychotherapy (KAP). Celeste is currently a co founder and the Clinical Director at Evolve Mind Wellness where we provide KAP.
Suegee Tamar-Mattis, DO, is a board-certified Family Medicine physician, certified in psychedelic-assisted therapies and research from the California Institute for Integral Studies, and trained in ketamine-assisted psychotherapy at the Polaris Insight Center. Dr. Tamar-Mattis has worked for many community organizations such as Sonoma County Indian Health Project and Brookwood Health Center (serving people experiencing homelessness), and was the founder of the transgender clinic at Santa Rosa Community Health Centers. Dr. Tamar-Mattis is a long-time advocate for the intersex community, serving as a consultant for Human Rights Watch and as a medical advisor to interACT: Advocates for Intersex Youth.
1. Understand what Ketamine is and what role it has in mental health treatment.
2. Become familiar with general principles of psychedelic-assisted psychotherapy, and understand the values and philosophies embedded in psychedelic medicine work as they contrast with psychiatric prescribing and conventional therapies.
- Identify three key indications for KAP and identify realistic expectations for potential treatment outcomes.
- Identify two parts of KAP protocol in order to communicate with clients and potential prescribers.
- Be able to identify two issues in ethics and care delivery in psychedelic medicine.
- Identify three key indications for KAP and have realistic expectations for potential treatment outcomes.
- Be able to identify one way in which group KAP may specifically benefit marginalized and under-served communities.
Stein, M. B., Simon, N. M., Simon, N. M., Psychiatry. (2021, February 1). Ketamine for PTSD: Well, isn’t that special. American Journal of Psychiatry. Retrieved May 10, 2022, from https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2020.20121677
Halstead, MS, M., Krause, DNP, APRN-BC, R., Reed, MS, Monnica Williams PhD, ABPP, M. T. (2021). Ketamine-assisted psychotherapy for PTSD related to Racial Discrimination . Ketamine-Assisted Psychotherapy for PTSD Related to Racial Discrimination. Retrieved May 11, 2022, from https://journals.sagepub.com/doi/full/10.1177/1534650121990894
McInnes, L. A., Qian, J. J., Gargeya, R. S., DeBattista, C; Heifets, B. D. (2022, January 11). A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings. Journal of Affective Disorders. Retrieved May 10, 2022, from https://www.sciencedirect.com/science/article/pii/S0165032721014142#sec0007
Zydb, T.; Hart, M. I. (n.d.). Efficacy of oral ketamine combined with psychotherapy for treatment resistant depression. European Journal of Medical and Health Sciences. Retrieved May 10, 2022, from https://www.ejmed.org/index.php/ejmed/article/view/979
Mind blog: Ketamine in contextual trauma therapy: The paradox of dissociation. MIND Foundation. (2022, February 17). Retrieved May 10, 2022, from https://mind-foundation.org/cptsd-ketamine-dissociation/
I. 2:00 pm – 2:15 – What is Ketamine?
A. History and science of Ketamine
B. How is it used presently in mental health and psychiatry
C. Clinical data as well as anecdotal reports
D. Antidepressant effect and biological model of depression (NMDA and glutamine)
E. Functional model of neuroplasticity (BDNF, DMN, catalyst for change, etc)
II. 2:15 – 2:30 – Ketamine-Assisted Psychotherapy and other models
A. Psychedelic assisted psychotherapy (MDMA, Psilocybin)
B. Ketamine and Psychotherapy- KAP (prep/session/Integration)
C. Psycholytic vs psychedelic
D. Acute SI and treatment
E. How does the Route of Administration affect the healing potential?
III. 2:30-2:45 – How KAP can augment traditional therapy
A. Who is a good candidate for KAP?
B. Contraindications for KAP
C. How can KAP providers work with referring therapists?
D. Tempering expectations of KAP – what it can do and what it can’t
IV. 2:45-3:00 – What methods do we employ at Evolve?
V. 3:00-3:15 Emerging models- KAP in group settings
A. Using KAP group sessions in marginalized communities
B. Using KAP group sessions with first responders
VI. Training for KAP 3:15-3:30
A. Where and how to find specialized training
B. The importance of experiential training when working with NOSC (Non-Ordinary States of Consciousness) and integrating client medicine stories.
VII. Questions – 30 minutes
You can sign up for this workshop here.
Free for associates, alumni and supervisors of Grateful Heart. $70 for associates and $120 for licensed clinicians who are not affiliated with Grateful Heart. Registration deadline is August 8th. Questions about this training can be emailed to email@example.com.